Mode
Text Size
Log in / Sign up
N/A Completed N=40 Randomized Quadruple-blind Treatment

Clinical Trial Evaluating the Efficiency of Holmium Laser Settings on Urinary Stones

Stone Ureter · Stone;Renal · Surgery
Source: ClinicalTrials.gov NCT03526458 ↗
Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Aug 2021
Primary outcomePrimary: Fragmentation Time — 24.5; 7.9 Minutes — p=0.012

Summary

The primary objective of this study is to compare the time to acceptable stone fragmentation during clinical use of the holmium laser when using energy settings 0.2J vs 0.8J. The hypothesis is that holmium laser energy settings 0.8J will require less time than lower energy settings 0.2J for fragmenting urinary stones. The clinical practice is to treat urinary stones until the stone is reduced to fragments ≤ 2 mm in size. This is determined by using the laser fiber which is 273 microns to visually estimate the size of the resultant fragments as described by Patel et al, J Endo 2014. Investigators will standardize the effect of stone size by creating a ratio of stone size to treatment time. In this study, the frequency is set at 15Hz. Thus, the study contains two arms: 0.2J&15Hz, and 0.8J&15Hz. Patients will be randomized into the two groups by the ratio of 1:1.

Outcome Measures

OutcomeResultp-value
PRIMARY
Fragmentation Time
24.5; 7.9 0.012 sig
SECONDARY
Total Operative Time
75.7; 64.3 0.132
SECONDARY
Pre-Operative Stone Size
11.2; 9.2 0.654
SECONDARY
Number of Participants With Either Ureteral or Renal Location of Urinary Stone
8; 7; 4; 8 0.299
SECONDARY
Number of Participants Treated for Either Single or Multiple Urinary Stones
8; 14; 4; 1 0.076
SECONDARY
Density of Urinary Stones
935.2; 924.7 0.943
SECONDARY
Number of Participants With Urinary Stone Fragment Size of 1, 2 or 3 mm
1; 5; 10; 10; 1; 0 0.185

Eligibility Criteria

Inclusion Criteria

  • Patients at least 18 years of age
  • Patients with urinary stones who require endoscopic treatment

Exclusion Criteria

  • Patients < 18 years of age
  • Pregnant patients
  • Pre-menopausal females who have not been on approved birth control for at least 1 month pre-operatively
  • Patients with stones known to be refractory to treatment with the holmium laser
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03526458). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search